165 related articles for article (PubMed ID: 3353539)
1. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
2. Problem behavior and psychiatric impairment within a developmentally disabled population I: behavior frequency.
Jacobson JW
Appl Res Ment Retard; 1982; 3(2):121-39. PubMed ID: 7125639
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with psychotropic medication in mental retardation facilities.
Tu J; Smith JT
Compr Psychiatry; 1979; 20(3):289-95. PubMed ID: 446009
[No Abstract] [Full Text] [Related]
4. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
[TBL] [Abstract][Full Text] [Related]
5. Problem behavior and psychiatric impairment within a developmentally disabled population. II: Behavior severity.
Jacobson JW
Appl Res Ment Retard; 1982; 3(4):369-81. PubMed ID: 7168573
[No Abstract] [Full Text] [Related]
6. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
Lunsky Y; Modi M
Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
[TBL] [Abstract][Full Text] [Related]
11. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
Spreat S; Conroy J
Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
[TBL] [Abstract][Full Text] [Related]
12. Developmentally disabled, doubly disadvantaged.
Parker G
Med J Aust; 1991 Jul; 155(2):68-71. PubMed ID: 1857308
[No Abstract] [Full Text] [Related]
13. The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments.
Hogg J
J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():473-88. PubMed ID: 1477486
[TBL] [Abstract][Full Text] [Related]
14. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
15. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication of mentally retarded residents in community long-term care facilities.
Buck JA; Sprague RL
Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
18. Caregiver perceptions of psychotropic medication in residential facilities.
Aman MG; Singh NN; White AJ
Res Dev Disabil; 1987; 8(3):449-65. PubMed ID: 3671821
[TBL] [Abstract][Full Text] [Related]
19. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
[TBL] [Abstract][Full Text] [Related]
20. [Mental health among mentally disabled persons].
Skullerud E; Linaker OM; Svenning AC; Torske H
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3246-8. PubMed ID: 11187162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
